Factors associated with attrition of African Americans during the recruitment phase of a clinical trial examining adherence among individuals with rheumatoid arthritis

被引:25
作者
Dunbar-Jacob, J
Holmes, JL
Sereika, S
Kwoh, CK
Burke, LE
Starz, TW
McCall, M
Foley, SM
机构
[1] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA
[4] Arthrit & Internal Med Associates, Pittsburgh, PA USA
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2004年 / 51卷 / 03期
关键词
minority; African American; rheumatoid arthritis; attrition; recruitment;
D O I
10.1002/art.20411
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective. To examine factors contributing to the loss of potential minority participants in a study of medication adherence among rheumatoid arthritis patients. Methods. Chi-square statistics were used to test for differences in refusal/ineligibility by race and site at 4 screening points (initial eligibility review, initial patient contact, adherence screening, and informed consent). Differences in criteria-specific risks for exclusion at initial eligibility review were examined across 4 sites by race. Odds ratios (95% confidence intervals) were estimated if differences were significant. Multivariate logistic regression was used to examine sociodemographic factors associated with the probability for ineligibility at the initial eligibility review. Stated reasons for refusal were qualitatively quantified. Results. A greater percentage of African Americans were lost at every screening point when compared with whites, but only the difference at the initial eligibility review was statistically significant. Conclusion. Factors associated with attrition included selection of area medical sites, research design issues, comorbid conditions, alcohol abuse, and being younger, unmarried, African American, and male.
引用
收藏
页码:422 / 428
页数:7
相关论文
共 34 条
[1]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]
Charles H, 2003, J NATL MED ASSOC, V95, P17
[3]
WHO DROPS OUT OF CLINICAL-TRIALS - THE VA COOPERATIVE STUDY EXPERIENCE [J].
COLLINS, JF ;
BINGHAM, SF ;
WILLIFORD, WO ;
WEISS, DG .
CONTROLLED CLINICAL TRIALS, 1981, 2 (01) :78-78
[4]
HOW OFTEN IS MEDICATION TAKEN AS PRESCRIBED - A NOVEL ASSESSMENT TECHNIQUE [J].
CRAMER, JA ;
MATTSON, RH ;
PREVEY, ML ;
SCHEYER, RD ;
OUELLETTE, VL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (22) :3273-3277
[5]
*DEP CIT PLANN, 1991, 1990 CENS POP HOUS R, P22
[6]
DEVELLIS BM, 1988, PATIENT EDUC COUNS, V11, P29
[7]
Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects [J].
Evans, WE ;
McLeod, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :538-549
[8]
FAOUAD M, 2000, ANN EPIDEMIOL, V10, P35
[9]
FELSON DT, 1993, ARTHRITIS ALLIED CON, P17
[10]
FLEWELLING RL, 1992, USDHHS PUBLICATION, P21